Published in Br J Pharmacol on June 01, 1975
Review lecture. Neurotransmitters and trophic factors in the autonomic nervous system. J Physiol (1981) 2.85
On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings. J Physiol (1984) 1.98
On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol (1987) 1.56
ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings. J Physiol (1994) 1.51
Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol (1981) 1.45
On the calcium receptor that mediates depolarization-secretion coupling at cholinergic motor nerve terminals. Br J Pharmacol (1981) 1.45
Evidence for specific adenosine receptors at cholinergic nerve endings. Br J Pharmacol (1980) 1.43
Adenosine 5'-triphosphate activates acetylcholine receptor channels in cultured Xenopus myotomal muscle cells. J Physiol (1988) 1.16
On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol (1985) 1.13
Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. J Physiol (1996) 1.12
Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol (1991) 1.08
Depression of evoked potentials in brain slices by adenosine compounds. Br J Pharmacol (1978) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br J Pharmacol (1990) 1.07
Adenosine inhibition of gamma-aminobutyric acid release from slices of rat cerebral cortex. Br J Pharmacol (1980) 1.07
Sources of adenosine released during neuromuscular transmission in the rat. J Physiol (1991) 1.07
On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction. Br J Pharmacol (1988) 1.05
Adenosine decreases neurotransmitter release at central synapses. Proc Natl Acad Sci U S A (1992) 1.01
Probabilistic secretion of quanta from nerve terminals in toad (Bufo marinus) muscle modulated by adenosine. J Physiol (1991) 0.96
Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One (2013) 0.94
Purinergic signalling in the musculoskeletal system. Purinergic Signal (2013) 0.93
Tuning and fine-tuning of synapses with adenosine. Curr Neuropharmacol (2009) 0.89
Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings. J Physiol (2003) 0.86
Potentiation by ATP of the postsynaptic acetylcholine response at developing neuromuscular synapses in Xenopus cell cultures. J Physiol (1994) 0.81
Potentiation by endogenously released ATP of spontaneous transmitter secretion at developing neuromuscular synapses in Xenopus cell cultures. Br J Pharmacol (1994) 0.79
Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PLoS One (2014) 0.79
Potentiation of miniature endplate potential frequency by ATP in Xenopus tadpoles. Br J Pharmacol (1993) 0.79
LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II. Purinergic Signal (2005) 0.75
Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission. Purinergic Signal (2015) 0.75
An analysis of the end-plate potential recorded with an intracellular electrode. J Physiol (1951) 83.81
Quantal components of the end-plate potential. J Physiol (1954) 37.52
A further study of the statistical composition on the end-plate potential. J Physiol (1955) 19.64
Purinergic nerves. Pharmacol Rev (1972) 12.05
The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol (1970) 5.15
The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol (1972) 3.16
Cyclic adenosine monophosphate, CA++, and membranes. Proc Natl Acad Sci U S A (1968) 2.46
Effects of iontophoretically applied drugs on spinal interneurons of the lamprey. J Physiol (1970) 1.61
The effects of extracellularly applied ATP and related compounds on electrical and mechanical activity of the smooth muscle taenia coli from the guinea-pig. Acta Physiol Scand (1969) 1.55
A cyclic adenosine monophosphate link in the catecholamine enhancement of transmitter release at the neuromuscular junction. J Gen Physiol (1974) 1.38
Coronary vasodilator properties of purine and pyrimidine derivatives. Circ Res (1956) 1.27
Coronary dilator action of the adenine-ATP series. J Pharmacol Exp Ther (1953) 1.11
Specificity of adenosine on transmitter output at the neuromuscular junction. Br J Pharmacol (1973) 1.02
Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius. Br J Pharmacol (1973) 0.95
Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science (1996) 5.44
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum (1993) 5.05
A highly conserved repeated DNA element located in the chromosome of Streptococcus pneumoniae. Nucleic Acids Res (1992) 3.73
Acquired immunodeficiency syndrome in New York City. Evaluation of an active surveillance system. JAMA (1985) 3.45
Is phimosis overdiagnosed in boys and are too many circumcisions performed in consequence? Ann R Coll Surg Engl (1989) 3.23
Worthing physiological scoring system: derivation and validation of a physiological early-warning system for medical admissions. An observational, population-based single-centre study. Br J Anaesth (2007) 2.98
Women prefer hospital births. BMJ (1992) 2.88
Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA (1989) 2.53
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? Mol Genet Metab (2003) 2.29
Adenosine receptors and calcium: basis for proposing a third (A3) adenosine receptor. Prog Neurobiol (1986) 2.26
Barriers to care among persons living with HIV/AIDS in urban and rural areas. AIDS Care (1998) 2.25
Bacteriophytochromes are photochromic histidine kinases using a biliverdin chromophore. Nature (2001) 2.22
HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes (2001) 2.18
Increasing the rate of chromatin remodeling and gene activation--a novel role for the histone acetyltransferase Gcn5. EMBO J (2001) 2.04
Increasing prevalence of obesity in primary school children: cohort study. BMJ (2001) 2.04
The Wessex Growth Study: first report. Acta Paediatr Scand Suppl (1989) 2.02
Where next for prophylaxis against pre-eclampsia? Br J Obstet Gynaecol (1996) 1.95
Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr (1992) 1.95
Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol (1988) 1.95
Studies on the Toxemia Syndrome After Burns II: Central Nervous System Changes as a Cause of Death. Ann Surg (1945) 1.89
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess (2001) 1.87
Predicting length of stay, functional outcome, and aftercare in the rehabilitation of stroke patients. The dominant role of higher-order cognition. Stroke (1993) 1.73
Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science (1992) 1.69
The relationship between beliefs about nutrition and dietary practices of the elderly. J Am Diet Assoc (1990) 1.67
Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci (1998) 1.65
Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations. Appl Nurs Res (1995) 1.65
Effect of preoperative anaesthetic visit on anxiety. Br Med J (1977) 1.64
Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun (1989) 1.64
Colorectal carcinoma in children and adolescents--a report of seven cases. Eur J Pediatr Surg (2001) 1.64
Diagnosis of malaria in a remote area of the Philippines: comparison of techniques and their acceptance by health workers and the community. Bull World Health Organ (2001) 1.63
An assessment of the accuracy of clinical diagnosis, local microscopy and a rapid immunochromatographic card test in comparison with expert microscopy in the diagnosis of malaria in rural Kenya. Trans R Soc Trop Med Hyg (2000) 1.62
Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol Biochem Parasitol (2000) 1.62
Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group. Diabetes Care (1993) 1.60
Rectal examination in paediatric surgical practice. Br J Surg (1999) 1.58
Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry. J Med Microbiol (2000) 1.57
Human health implications of environmental contaminants in Arctic Canada: a review. Sci Total Environ (1999) 1.57
Relief from chronic pain by low power laser irradiation. Neurosci Lett (1983) 1.56
Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet (2002) 1.50
Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol (2003) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod (2012) 1.46
Effect of adenosine on carotid chemoreceptor activity in the cat. Br J Pharmacol (1981) 1.45
Schistosomiasis in Australian travellers to Africa. Med J Aust (1997) 1.43
An interstate drowning study. Am J Public Health Nations Health (1968) 1.42
The role of the practice nurse in the management of depression in general practice: treatment adherence to antidepressant medication. Psychol Med (1993) 1.41
K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin Chem (2000) 1.40
Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. J Exp Med (1973) 1.39
Induction for rapid sequence induction: a tri-deanery survey. Anaesthesia (2012) 1.39
Homology of cryptic plasmid of Neisseria gonorrhoeae with plasmids from Neisseria meningitidis and Neisseria lactamica. J Clin Pathol (1986) 1.38
HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer (2011) 1.38
Double-blind study of lorazepam and diazepam in status epilepticus. JAMA (1983) 1.37
Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. J Biol Chem (1979) 1.37
Rapid virological surveillance of community influenza infection in general practice. BMJ (2000) 1.31
The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 is functionally significant. J Gen Virol (1992) 1.30
On the specificity and type of receptor involved in carotid body chemoreceptor activation by adenosine in the cat. Br J Pharmacol (1983) 1.26
Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet (1986) 1.26
Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol (1996) 1.24
Historical population movements in Europe influence genetic relationships in modern samples. Hum Biol (1996) 1.23
Mood assessment in chronic pain patients. Disabil Rehabil (1994) 1.23
Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J Hosp Infect (2010) 1.23
Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci (2000) 1.22
Dual roles of p82, the clam CPEB homolog, in cytoplasmic polyadenylation and translational masking. RNA (1999) 1.21
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) Clin Infect Dis (1999) 1.20
Adenosine and adenosine triphosphate decrease 45Ca uptake by synaptosomes stimulated by potassium. Biochem Pharmacol (1979) 1.20
Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer (2011) 1.19
Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study. Br J Cancer (2007) 1.19
Adenosine: does it have a neuroprotective role after all? Brain Res Brain Res Rev (2000) 1.18
Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem (1996) 1.17
Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res (1994) 1.17
Developing a standard short questionnaire for the assessment of patient satisfaction with out-of-hours primary care. Fam Pract (2005) 1.16
Azo reduction of sulphasalazine in healthy volunteers. Br J Clin Pharmacol (1982) 1.15
A high-resolution microsatellite map of the mouse genome. Genome Res (1998) 1.14
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol (2007) 1.14
On the type of receptor involved in the inhibitory action of adenosine at the neuromuscular junction. Br J Pharmacol (1985) 1.13
Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol (1999) 1.13
Late results of saphenous vein bypass grafting for myocardial revascularization. Ann Thorac Surg (1972) 1.13
ATP as a presynaptic modulator. Life Sci (2000) 1.12
Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology (2011) 1.12
Rising obesity and expanding waistlines in schoolchildren: a cohort study. Arch Dis Child (2004) 1.12
[Experimental study of bacteriophage removal from the lagoon basin]. Can J Microbiol (1980) 1.11
The ubiquitin-specific protease UBP14 is essential for early embryo development in Arabidopsis thaliana. Plant J (2001) 1.11
Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial. Ann Oncol (2012) 1.11
Multiply scattered light tomography and confocal imaging: detecting neovascularization in age-related macular degeneration. Opt Express (2000) 1.10
An integrated "4-phase" approach for setting endocrine disruption screening priorities--phase I and II predictions of estrogen receptor binding affinity. SAR QSAR Environ Res (2002) 1.10
Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance. J Anim Sci (2001) 1.10
Adenocarcinoma of the cervix associated with human papillomavirus. Cancer (1988) 1.09
Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience (2002) 1.09
Homoserine kinase from Escherichia coli K12. Eur J Biochem (1976) 1.09
THE CULTIVATION OF AMOEBAE IN PURE CULTURE UPON AUTOLYZED TISSUES. J Exp Med (1913) 1.09
Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol (1991) 1.08
Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther (1976) 1.08
Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg (2010) 1.08
Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement. J Ultrasound Med (2001) 1.08
The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol (1990) 1.07
Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br J Pharmacol (1990) 1.07
Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus. Neurosci Lett (1992) 1.07
Canadian physicians and tobacco. CMAJ (1991) 1.07
Mechanisms of depression of neuromuscular transmission by ATP and adenosine. J Physiol (Paris) (1978) 1.07